BetterLife Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Millions USD. Fiscal year is Feb - Jan.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 21, 2026	Jan '26 Jan 31, 2026	Jan '25 Jan 31, 2025	Jan '24 Jan 31, 2024	Jan '23 Jan 31, 2023	Jan '22 Jan 31, 2022
Market Capitalization	25	6	11	6	10	14
Market Cap Growth	131.91%	-49.81%	77.29%	-35.21%	-26.56%	-75.00%
Enterprise Value	28	9	15	8	13	12
Last Close Price	0.16	0.04	0.09	0.06	0.11	0.16
PB Ratio	-5.34	-1.21	-2.26	-1.13	-1.77	-4.47
Debt / Equity Ratio	-0.15	-0.14	-0.18	-0.07	-0.02	-0.08
Net Debt / Equity Ratio	-0.14	-0.14	-0.18	-0.07	-0.02	-0.04
Net Debt / EBITDA Ratio	-	-	-	-0.16	-0.02	-0.01
Net Debt / FCF Ratio	-1.09	-1.43	-0.65	-0.21	-0.12	-0.01
Quick Ratio	0.01	0.00	0.00	0.01	0.00	0.12
Current Ratio	0.04	0.03	0.03	0.04	0.01	0.28
Return on Assets (ROA)	-500.55%	-508.19%	-1074.42%	-1004.42%	-936.16%	-493.00%
Return on Capital Employed (ROCE)	29.60%	28.00%	64.60%	45.70%	130.90%	334.40%
Earnings Yield	-5.51%	-19.10%	-21.15%	-33.29%	-67.53%	-70.08%
FCF Yield	-	-7.99%	-12.15%	-28.49%	-11.26%	-64.57%
Buyback Yield / Dilution	-19.26%	-17.77%	-13.34%	-26.25%	-14.70%	-179.24%